Physician profile
Reginald S Opimo
NPI 1801833629
$5,734.11
in general payments reported to CMS, 2019-2025
8 companies · $1,069 in 2025
The $1,069 reported for 2025 was more than what 96% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,757 · 2020: $316 · 2021: $617 · 2022: $68.49 · 2023: $1,594 · 2024: $313 · 2025: $1,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,631 · Education: $588 · Entertainment: $500 · Gift: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.21 |
| Education | $587.50 |
| Entertainment | $500.00 |
| Gift | $256.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $3,084.55 | 2019-2025 | Cerec, Suresmile, Implant Dentistry |
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Zimvie INC. | $317.39 | 2023-2024 | |
| Keystone Dental INC. | $279.86 | 2019-2020 | |
| 3m Company | $263.33 | 2020 | |
| Ultradent Products INC | $256.98 | 2025 | Opalescence |
| Sonendo INC | $18.58 | 2022 | |
| Envista Holdings Corporation | $13.42 | 2024 | Optibond All-In-One |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reginald Opimo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.